Related Experiment Video

Updated: Aug 16, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Drug-induced aseptic meningitis in suspected central nervous system infections

L Kepa1, B Oczko-Grzesik, W Stolarz

  • 1Department of Infectious Diseases, Medical University of Silesia, Bytom, Poland. bgrzesik@hoga.pl

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|July 30, 2005
PubMed

Insights

Drug-induced aseptic meningitis (DIAM) mimics central nervous system infections. Nonsteroidal anti-inflammatory drugs are a common cause, highlighting the need for detailed medication history in diagnosis.

Area of Science:

  • Neurology
  • Pharmacology
  • Infectious Diseases

Background:

  • Central nervous system (CNS) infections require prompt diagnosis and treatment.
  • Drug-induced aseptic meningitis (DIAM) can present with symptoms mimicking CNS infections.
  • Distinguishing DIAM from infectious etiologies is crucial for appropriate patient management.

Observation:

  • Eight patients initially suspected of CNS infection were diagnosed with DIAM.
  • Clinical and cerebrospinal fluid (CSF) findings were consistent with DIAM criteria.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) were identified as the most frequent cause of DIAM.

Findings:

  • The onset of DIAM symptoms occurred 2–7 days after exposure to the causative drug.
  • CSF profiles and clinical presentations of DIAM are often indistinguishable from early CNS infections.
  • A detailed medication history, including recent drug use, is essential for DIAM diagnosis.

Implications:

  • DIAM should be considered in the differential diagnosis of suspected CNS infections.
  • Thorough patient anamnesis regarding recent medication use is critical for accurate diagnosis.
  • Early recognition of DIAM can prevent unnecessary antimicrobial treatment and guide appropriate therapy.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for the Detection of Central Nervous System Pathogens10:08

Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for the Detection of Central Nervous System Pathogens

Published on: April 17, 2026

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...